Successful FY '25 Performance
EPS reached $1.26, at the upper end of guidance. Organic growth was 8%, translating to a 10% EBIT growth, with adjusted EPS growth approaching 20%. Shareholders were rewarded with a 30% dividend increase.
Industrial Segment Record Results
Record sales, record EBIT margin, and record profitability with organic growth approaching 6% and 10% EBIT growth.
Healthcare Segment Recovery
Healthcare showed strong growth with almost 10% organic growth and improved EBIT margins after overcoming destocking effects.
KBU Acquisition Outperformance
KBU business performance was ahead of the business case, integration completed, synergies target increased from $10 million to $15 million.
Sustainability Achievements
Reduction in injuries by 16% and recognition for sustainability efforts with net zero targets including Scope 3 emissions validated by the science-based targets initiative.